Skip to main content

Table 4 Analysis of association of TGM2 polymorphism (rs4811528) with the development of DS in APL patients

From: The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation syndrome in acute promyelocytic leukemia

Model Genotype DS (%) No DS (%) OR (95% CI) P-value AIC BIC
Codominant A/A 13 (72.2) 37 (32.2) 1.00 0.0096 90.2 104.7
A/G 4 (22.2) 54 (47) 5.61 (1.53–20.48)
G/G 1 (5.6) 24 (20.9) 6.14 (0.70–53.45)
Dominant A/A 13 (72.2) 37 (32.2) 1.00 0.0023 88.2 99.8
A/G-G/G 5 (27.8) 78 (67.8) 5.72 (1.74–18.81)
Recessive A/A-A/G 17 (94.4) 91 (79.1) 1.00 0.24 96.2 107.7
G/G 1 (5.6) 24 (20.9) 3.03 (0.36–25.25)
Over dominant A/A-G/G 14 (77.8) 61 (53) 1.00 0.02 92.1 103.6
A/G 4 (22.2) 54 (47) 4.06 (1.14–14.44)
Log-additive 3.78 (1.37–10.44) 0.004 89.2 100.8
  1. AIC Akaike Information criterion, BIC Bayesian Information